Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Ross

Showing results (131-140 of 244) with videos related to

Pageof 25
Sort By:
Neuroimage|October 24, 2009
Longitudinal characterization of brain atrophy of a Huntington's disease mouse model by automated morphological analyses of magnetic resonance imagesJiangyang Zhang, Qi Peng, Qing Li, et al.
Human Molecular Genetics|April 25, 2002
Targeted disruption of Huntingtin-associated protein-1 (Hap1) results in postnatal death due to depressed feeding behaviorEdmond Y W Chan, Jamal Nasir, Claire-Anne Gutekunst, et al.
Life Science Alliance|March 18, 2026
Huntingtin (HTT) interactome in regulation of DNA repair/remodeling and RNA processing pathwaysTamara Ratovitski, Chloe D Holland, Robert N O'Meally, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2002
Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowthYuji Ozeki, Toshifumi Tomoda, John Kleiderlein, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 30, 2009
Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD studyKevin M Biglan, Christopher A Ross, Douglas R Langbehn, et al.
Scientific Reports|July 29, 2015
Nuclear retention of full-length HTT RNA is mediated by splicing factors MBNL1 and U2AF65Xin Sun, Pan P Li, Shanshan Zhu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 26, 2024
In vivo self-assembled siRNAs within small extracellular vesicles attenuate LRRK2-induced neurodegeneration in Parkinson's disease modelsLi Zhang, Penglu Chen, Tiantian Chen, et al.
The Journal of Biological Chemistry|June 1, 2012
trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington DiseaseJinrong Fu, Jing Jin, Robert H Cichewicz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2012
Striatal neuronal loss correlates with clinical motor impairment in Huntington's diseaseZhihong Guo, Gay Rudow, Olga Pletnikova, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2008
A Drosophila model for LRRK2-linked parkinsonismZhaohui Liu, Xiaoyue Wang, Yi Yu, et al.
Pageof 25

Showing results (131-140 of 244) with videos related to

Sort By:
Pageof 25
Neuroimage|October 24, 2009
Longitudinal characterization of brain atrophy of a Huntington's disease mouse model by automated morphological analyses of magnetic resonance imagesJiangyang Zhang, Qi Peng, Qing Li, et al.
Human Molecular Genetics|April 25, 2002
Targeted disruption of Huntingtin-associated protein-1 (Hap1) results in postnatal death due to depressed feeding behaviorEdmond Y W Chan, Jamal Nasir, Claire-Anne Gutekunst, et al.
Life Science Alliance|March 18, 2026
Huntingtin (HTT) interactome in regulation of DNA repair/remodeling and RNA processing pathwaysTamara Ratovitski, Chloe D Holland, Robert N O'Meally, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2002
Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowthYuji Ozeki, Toshifumi Tomoda, John Kleiderlein, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 30, 2009
Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD studyKevin M Biglan, Christopher A Ross, Douglas R Langbehn, et al.
Scientific Reports|July 29, 2015
Nuclear retention of full-length HTT RNA is mediated by splicing factors MBNL1 and U2AF65Xin Sun, Pan P Li, Shanshan Zhu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 26, 2024
In vivo self-assembled siRNAs within small extracellular vesicles attenuate LRRK2-induced neurodegeneration in Parkinson's disease modelsLi Zhang, Penglu Chen, Tiantian Chen, et al.
The Journal of Biological Chemistry|June 1, 2012
trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington DiseaseJinrong Fu, Jing Jin, Robert H Cichewicz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2012
Striatal neuronal loss correlates with clinical motor impairment in Huntington's diseaseZhihong Guo, Gay Rudow, Olga Pletnikova, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2008
A Drosophila model for LRRK2-linked parkinsonismZhaohui Liu, Xiaoyue Wang, Yi Yu, et al.
Pageof 25